Department of Surgery, Masan Samsung Hospital, Sungkyunkwan University School of Medicine, Masan, Korea.
J Korean Med Sci. 2009 Oct;24(5):831-6. doi: 10.3346/jkms.2009.24.5.831. Epub 2009 Sep 23.
Complement 1 (C1) inhibitor is an acute phase protein with anti-inflammatory properties. The aim of the present study was to elucidate the relationship between brachial ankle pulse wave velocity (baPWV), the parameter of arterial stiffness, and C1 inhibitor. One hundred subjects were randomly enrolled in this study. Data about baPWV, age, gender, hypertension, smoking, and body mass index (BMI) were measured. Blood tests for total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, hemoglobin A1c, erythrocyte sedimentation rate, C-reactive protein, complement 3, and C1 inhibitor were performed. Based on the Pearson correlation, the C1 inhibitor showed a positive relation to the baPWV (P<0.001). Multiple regression analysis revealed the significant predictors of baPWV were not only the conventional risk factors of arteriosclerosis and/or atherosclerosis, such as age (P<0.001), gender (P<0.001), hypertension (P<0.001), and BMI (P=0.006), but also the acute phase protein, C1 inhibitor (P=0.025). In conclusion, C1 inhibitor is associated with arterial stiffness through its association with increased inflammation.
补体 1(C1)抑制剂是一种具有抗炎特性的急性期蛋白。本研究旨在阐明肱踝脉搏波速度(baPWV),即动脉僵硬度参数与 C1 抑制剂之间的关系。本研究随机纳入了 100 名受试者。测量了 baPWV、年龄、性别、高血压、吸烟和体重指数(BMI)等数据。进行了总胆固醇、低密度脂蛋白、高密度脂蛋白、甘油三酯、糖化血红蛋白、红细胞沉降率、C 反应蛋白、补体 3 和 C1 抑制剂的血液检查。根据 Pearson 相关性,C1 抑制剂与 baPWV 呈正相关(P<0.001)。多元回归分析显示,baPWV 的显著预测因子不仅包括动脉硬化和/或动脉粥样硬化的常规危险因素,如年龄(P<0.001)、性别(P<0.001)、高血压(P<0.001)和 BMI(P=0.006),还有急性期蛋白 C1 抑制剂(P=0.025)。总之,C1 抑制剂通过与炎症增加相关而与动脉僵硬有关。